Suboptimal exposure to fluconazole in critically ill patients: Pharmacokinetic analysis and determinants

AmarCAND2 study group, Leroy O, Bailly S, Gangneux JP, Mira JP, Devos P, et al. Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study. Annals of Intensive Care [Internet]. déc 2016 [cité 7 févr 2019];6(1). Disponible sur: http://www.annalsofintensivecare.com/content/6/1/2. Soulountsi, 2021, Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?, Infectiondéc, 49, 1107, 10.1007/s15010-021-01640-7 Bienvenu, 2020, Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis, Int J Infect Dis Avr, 93, 15, 10.1016/j.ijid.2020.01.037 Sinnollareddy MG, Roberts JA, Lipman J, Akova M, Bassetti M, De Waele JJ, et al. Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study. Crit Care 4 févr 2015;19:33. Bassetti, 2017, Intensive care medicine research agenda on invasive fungal infection in critically ill patients, Intensive Care Medsept, 43, 1225, 10.1007/s00134-017-4731-2 Vena, 2020, Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?, Infect Dis Ther Mars, 9, 137, 10.1007/s40121-020-00280-y Boonstra JM, Märtson AG, Sandaradura I, Kosterink JG, van derWerf TS, Marriott DJE, et al. Optimization of fluconazole dosing for the prevention and treatment of invasive candidiasis based on the pharmacokinetics of fluconazole in critically-ill patients. Antimicrob Agents Chemother 23 déc 2020. Van Daele R, Wauters J, Lagrou K, Denooz R, Hayette MP, Gijsen M, et al. Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients. Microorganisms 30 sept 2021;9(10):2068. Abdul-Aziz, 2020, Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper, Intensive Care Med Juin, 46, 1127, 10.1007/s00134-020-06050-1 Bienvenu AL, Argaud L, Aubrun F, Fellahi JL, Guerin C, Javouhey E, et al. A systematic review of interventions and performance measures for antifungal stewardship programmes. J Antimicrob Chemother 1 févr 2018;73(2):297–305.